All categoriesCJC-1295HEXARELINIGF-1-LR3IPAMORELINSERMORELINTESAMORELIN
Category
Growth Hormone Secretagogues
Ghrelin-receptor agonists and GHRH analogues studied for endogenous GH/IGF-1 axis modulation.
Growth Hormone Secretagogues
CJC-1295
DAC:GRF · Modified GRF (1-29)
- MW
- 3367.9 g/mol (with DAC)
- Half-life
- ≈ 8 days (with DAC); ≈ 30 min (without)
- Class
- GHRH analogue (with or without Drug Affinity Complex)
Growth Hormone Secretagogues
Hexarelin
- MW
- 887.05 g/mol
- Half-life
- ≈ 70 min (IV)
- Class
- Synthetic GH-releasing hexapeptide (GHRP)
Growth Hormone Secretagogues
IGF-1 LR3
Long-R3-IGF-1
- MW
- 9111 g/mol
- Half-life
- ≈ 20–30 h (extended vs. native IGF-1)
- Class
- Modified recombinant insulin-like growth factor 1
Growth Hormone Secretagogues
Ipamorelin
- MW
- 711.86 g/mol
- Half-life
- ≈ 2 h
- Class
- Selective ghrelin/GHS-R1a agonist
Growth Hormone Secretagogues
Sermorelin
GHRH(1-29) · GRF 1-29
- MW
- 3358 g/mol
- Half-life
- ≈ 10–20 min (SC)
- Class
- GHRH(1-29) analogue
Growth Hormone Secretagogues
Tesamorelin
- MW
- 5135.9 g/mol
- Half-life
- ≈ 26 min (SC)
- Class
- Stabilized GHRH(1-44) analogue